These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6378241)

  • 21. Antigen-reactive gamma delta T cells in human leishmaniasis.
    Russo DM; Armitage RJ; Barral-Netto M; Barral A; Grabstein KH; Reed SG
    J Immunol; 1993 Oct; 151(7):3712-8. PubMed ID: 8376802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunofluorescence in cutaneous leishmaniasis.
    Brenner S; Srebrnik A; Hazaz B; Krakowski A
    Dermatologica; 1984; 168(4):175-77. PubMed ID: 6373419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The interface between the Leishmania-infected macrophage and the host's immune system.
    Russell DG; Medina-Acosta E; Golubev A
    Behring Inst Mitt; 1991 Feb; (88):68-79. PubMed ID: 2049048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis.
    Bottrel RL; Dutra WO; Martins FA; Gontijo B; Carvalho E; Barral-Netto M; Barral A; Almeida RP; Mayrink W; Locksley R; Gollob KJ
    Infect Immun; 2001 May; 69(5):3232-9. PubMed ID: 11292745
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on intracellular killing of Leishmania major and lysis of host macrophages by immune lymphoid cells in vitro.
    Pham TV; Mauël J
    Parasite Immunol; 1987 Nov; 9(6):721-36. PubMed ID: 2448731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells.
    Peters N; Sacks D
    Immunol Rev; 2006 Oct; 213():159-79. PubMed ID: 16972903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Leishmaniasis: effect of factors present in serum].
    Savoia D; Cestaro A; Biglino S
    G Batteriol Virol Immunol; 1990; 83(1-12):118-24. PubMed ID: 2133319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Histopathology of tegumentary leishmaniasis caused by Leishmania braziliensis braziliensis. 2. Tissue humoral response].
    de Magalhães AV; Moraes MA; Raick AN; Llanos-Cuentas A; Costa JM; Cuba CC; Marsden PD
    Rev Inst Med Trop Sao Paulo; 1986; 28(5):293-9. PubMed ID: 3296117
    [No Abstract]   [Full Text] [Related]  

  • 30. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta.
    Souza-Lemos C; de-Campos SN; Teva A; Côrte-Real S; Fonseca EC; Porrozzi R; Grimaldi G
    J Pathol; 2008 Nov; 216(3):375-86. PubMed ID: 18702174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
    Petersen EA; Neva FA; Oster CN; Bogaert Diaz H
    N Engl J Med; 1982 Feb; 306(7):387-92. PubMed ID: 6460184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major.
    Gaafar A; Veress B; Permin H; Kharazmi A; Theander TG; el Hassan AM
    Clin Immunol; 1999 Jun; 91(3):314-20. PubMed ID: 10370377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological studies of the elimination of Leishmania enriettii from skin lesions in the guinea-pig.
    Monroy A; Ridley DS; Heather CJ; Ridley MJ
    Br J Exp Pathol; 1980 Dec; 61(6):601-10. PubMed ID: 7459254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
    Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
    Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
    Reis AB; Teixeira-Carvalho A; Vale AM; Marques MJ; Giunchetti RC; Mayrink W; Guerra LL; Andrade RA; Corrêa-Oliveira R; Martins-Filho OA
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):102-16. PubMed ID: 16621021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.
    Aranha FC; Ribeiro U; Basse P; Corbett CE; Laurenti MD
    Scand J Immunol; 2005 Oct; 62(4):334-41. PubMed ID: 16253120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines in host-parasite interactions in leishmaniasis.
    Teixeira MJ; Teixeira CR; Andrade BB; Barral-Netto M; Barral A
    Trends Parasitol; 2006 Jan; 22(1):32-40. PubMed ID: 16310413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NF-kappaB-mediated repression of iNOS expression in Leishmania amazonensis macrophage infection.
    Calegari-Silva TC; Pereira RM; De-Melo LD; Saraiva EM; Soares DC; Bellio M; Lopes UG
    Immunol Lett; 2009 Dec; 127(1):19-26. PubMed ID: 19712696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.